Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 USD | +0.22% | -1.86% | +3.73% |
09/05 | Medincell: share price rises on resumption of trading | CF |
08/05 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.73% | 284B | |
+30.38% | 684B | |
+30.01% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+16.81% | 240B | |
+9.10% | 208B | |
-7.81% | 200B | |
+7.68% | 166B | |
-2.71% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Barclays Adjusts Price Target on AbbVie to $185 From $175, Maintains Overweight Rating